NexImmune analyst ratings
NexImmune analyst ratings
While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a initiated with a price target of $0.00 to $5.00. The current price NexImmune (NEXI) is trading at is $2.28, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/01/2022 | 119.3% | BTIG | → $5 | Initiates Coverage On | → Buy |
| 04/01/2022 | 207.02% | Barclays | $4 → $7 | Maintains | Overweight |
| 02/22/2022 | 470.18% | Raymond James | $21 → $13 | Maintains | Outperform |
| 11/15/2021 | 821.05% | Raymond James | $30 → $21 | Maintains | Outperform |
| 04/01/2021 | 1215.79% | Raymond James | → $30 | Initiates Coverage On | → Outperform |
| 03/09/2021 | 1435.09% | Cantor Fitzgerald | → $35 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 1 月 6 日 | 119.3% | BTIG | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 04/01/2022 | 207.02% | 巴克莱 | 4 美元 → 7 美元 | 维护 | 超重 |
| 02/22/2022 | 470.18% | 雷蒙德·詹姆 | 21 美元 → 13 美元 | 维护 | 跑赢大盘 |
| 11/15/2021 | 821.05% | 雷蒙德·詹姆 | 30 美元 → 21 美元 | 维护 | 跑赢大盘 |
| 2021 年 1 月 4 日 | 1215.79% | 雷蒙德·詹姆 | → 30 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2021 年 9 月 3 日 | 1435.09% | 坎托·菲茨杰拉德 | → 35 美元 | 启动覆盖范围开启 | → 超重 |
NexImmune Questions & Answers
nexImmune 问答
The latest price target for NexImmune (NASDAQ: NEXI) was reported by BTIG on June 1, 2022. The analyst firm set a price target for $5.00 expecting NEXI to rise to within 12 months (a possible 119.30% upside). 4 analyst firms have reported ratings in the last year.
BTIG于2022年6月1日公布了NexImmune（纳斯达克股票代码：NEXI）的最新目标股价。该分析公司将目标股价定为5.00美元，预计NEXI将在12个月内升至12个月内（可能上涨119.30％）。去年有4家分析公司公布了评级。
The latest analyst rating for NexImmune (NASDAQ: NEXI) was provided by BTIG, and NexImmune initiated their buy rating.
BTIG提供了NexImmune（纳斯达克股票代码：NEXI）的最新分析师评级，NexImmune启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexImmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexImmune was filed on June 1, 2022 so you should expect the next rating to be made available sometime around June 1, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与NexImmune的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。NexImmune 的最新评级是在 2022 年 6 月 1 日公布的，因此您应该预计，下一个评级将在 2023 年 6 月 1 日左右公布。
While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a initiated with a price target of $0.00 to $5.00. The current price NexImmune (NEXI) is trading at is $2.28, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的NexImmune（NEXI）评级最初是以0.00美元至5.00美元的目标股价为起步的。NexImmune（NEXI）目前的交易价格为2.28美元，在分析师的预测区间内。
